Literature DB >> 946537

Intravenous aminophylline dosage. Use of serum theophylline measurement for guidance.

M W Weinberger, R A Matthay, E J Ginchansky, C A Chidsey, T L Petty.   

Abstract

A practical method for monitoring serum theophylline concentrations has been used to investigate intravenous aminophylline dosage requirements. Initial serum theophylline concentrations were found to vary widely and correlate poorly with drug history. Aminophylline loading doses determined from these values more frequently resulted in drug concentrations in the therapeutic range (10 mug to 20 mug/ml) than when therapy was given without knowledge of serum theophylline concentrations. Continuous intravenous aminophylline therapy administered in a standardized dosage (0.9 mg/kg/hr in adults and 1.0 mg/kg/hr in children) produced variable and often excessive serum concentrations. This resulted from variable drug clearance rates, which in adults averaged 0.64 +/- 0.38 ml/kg/min (mean +/- SD), only half that previously reported. These observations suggest that it is not possible to achieve optimal therapeutic aminophylline dosage without monitoring serum theophylline concentrations.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 946537     DOI: 10.1001/jama.235.19.2110

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  17 in total

1.  Contemporary aminophylline use for status asthmaticus in pediatric ICUs.

Authors:  Abdallah Dalabih; Zena Leah Harris; Steven A Bondi; Donald H Arnold
Journal:  Chest       Date:  2012-04       Impact factor: 9.410

Review 2.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

Review 3.  Monitoring serum theophylline levels.

Authors:  L Hendeles; M Weinberger; G Johnson
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

Review 4.  Pulmonary disease and drug kinetics.

Authors:  P du Souich; A J McLean; D Lalka; S Erill; M Gibaldi
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

5.  The effect of assay methods on plasma levels and pharmacokinetics of theophylline: HPLC and EIA.

Authors:  T Ishizaki; M Watanabe; N Morishita
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

Review 6.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

7.  Diffusion and flow transfer of theophylline across the blood-brain barrier: pharmacokinetic analysis.

Authors:  M D Karol; P Veng-Pedersen; R E Brashear
Journal:  J Pharmacokinet Biopharm       Date:  1983-06

8.  Intravenous aminophylline in patients already taking oral theophylline: effect on calculated dose of knowledge of serum theophylline concentration on admission.

Authors:  J Wiggins; O A Arbab; D E Stableforth; J G Ayres
Journal:  Thorax       Date:  1986-10       Impact factor: 9.139

9.  Pharmacokinetics of theophylline in young children with asthma: comparison of rectal enema and suppositories.

Authors:  P Bolme; P O Edlund; M Eriksson; L Paalzow; B Winbladh
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

Review 10.  Pharmacokinetics in patients with cardiac failure.

Authors:  N L Benowitz; W Meister
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.